These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 22042412

  • 1. Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model.
    Godier A, Miclot A, Le Bonniec B, Durand M, Fischer AM, Emmerich J, Marchand-Leroux C, Lecompte T, Samama CM.
    Anesthesiology; 2012 Jan; 116(1):94-102. PubMed ID: 22042412
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.
    Martin AC, Le Bonniec B, Fischer AM, Marchand-Leroux C, Gaussem P, Samama CM, Godier A.
    Int J Cardiol; 2013 Oct 09; 168(4):4228-33. PubMed ID: 23928345
    [Abstract] [Full Text] [Related]

  • 3. Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.
    Perzborn E, Heitmeier S, Laux V, Buchmüller A.
    Thromb Res; 2014 Apr 09; 133(4):671-81. PubMed ID: 24529498
    [Abstract] [Full Text] [Related]

  • 4. Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates.
    Perzborn E, Gruber A, Tinel H, Marzec UM, Buetehorn U, Buchmueller A, Heitmeier S, Laux V.
    Thromb Haemost; 2013 Jul 09; 110(1):162-72. PubMed ID: 23636219
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of prothrombin complex concentrate to reverse the anticoagulant effect of the pentasaccharide fondaparinux in a rabbit model.
    Godier A, Durand M, Emmerich J, Dizier B, Lecompte T, Samama CM.
    Thromb Haemost; 2011 Jan 09; 105(1):161-8. PubMed ID: 20941458
    [Abstract] [Full Text] [Related]

  • 6. Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit.
    Le Saché F, Le Bonniec B, Gaussem P, Dizier B, Tagzirt M, Godier A, Emmerich J, Samama CM.
    Br J Anaesth; 2012 Apr 09; 108(4):586-93. PubMed ID: 22258204
    [Abstract] [Full Text] [Related]

  • 7. Recombinant activated factor VII does not reduce bleeding in rabbits treated with aspirin and clopidogrel.
    Hindy-François C, Bachelot-Loza C, Le Bonniec B, Grelac F, Dizier B, Godier A, Emmerich J, Gaussem P, Samama CM.
    Thromb Haemost; 2010 Oct 09; 104(4):823-30. PubMed ID: 20664889
    [Abstract] [Full Text] [Related]

  • 8. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
    Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M.
    Circulation; 2011 Oct 04; 124(14):1573-9. PubMed ID: 21900088
    [Abstract] [Full Text] [Related]

  • 9. Measurement and reversal of prophylactic and therapeutic peak levels of rivaroxaban: an in vitro study.
    Körber MK, Langer E, Ziemer S, Perzborn E, Gericke C, Heymann Cv.
    Clin Appl Thromb Hemost; 2014 Oct 04; 20(7):735-40. PubMed ID: 23832064
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recombinant activated factor VII decreases bleeding without increasing arterial thrombosis in rabbits.
    Fattorutto M, Tourreau-Pham S, Mazoyer E, Bonnin P, Raphaël M, Morin F, Cupa M, Samama CM.
    Can J Anaesth; 2004 Oct 04; 51(7):672-9. PubMed ID: 15310634
    [Abstract] [Full Text] [Related]

  • 12. Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers.
    Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.
    Thromb Haemost; 2012 Aug 04; 108(2):217-24. PubMed ID: 22627883
    [Abstract] [Full Text] [Related]

  • 13. Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study.
    Godier A, Mazoyer E, Cymbalista F, Cupa M, Samama CM.
    J Thromb Haemost; 2007 Feb 04; 5(2):244-9. PubMed ID: 17129221
    [Abstract] [Full Text] [Related]

  • 14. Novel oral anticoagulants: new challenges for anesthesiologists in bleeding patients.
    Spahn DR, Korte W.
    Anesthesiology; 2012 Jan 04; 116(1):9-11. PubMed ID: 21993157
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation.
    Dickneite G.
    Thromb Res; 2007 Jan 04; 119(5):643-51. PubMed ID: 16842841
    [Abstract] [Full Text] [Related]

  • 19. The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor.
    Schultz NH, Tran HTT, Bjørnsen S, Henriksson CE, Sandset PM, Holme PA.
    Thromb J; 2017 Jan 04; 15():6. PubMed ID: 28239301
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.